Company registration number 07120483 (England and Wales)
ASPIRE HEALTH AND CARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
PAGES FOR FILING WITH REGISTRAR
ASPIRE HEALTH AND CARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
ASPIRE HEALTH AND CARE LIMITED
BALANCE SHEET
AS AT 31 JANUARY 2025
31 January 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
755,851
787,229
Current assets
Debtors
4
374,107
223,320
Cash at bank and in hand
300,789
199,683
674,896
423,003
Creditors: amounts falling due within one year
5
(407,810)
(391,181)
Net current assets
267,086
31,822
Total assets less current liabilities
1,022,937
819,051
Creditors: amounts falling due after more than one year
6
(12,690)
(21,279)
Net assets
1,010,247
797,772
Capital and reserves
Called up share capital
8
1
1
Profit and loss reserves
1,010,246
797,771
Total equity
1,010,247
797,772

For the financial year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 10 October 2025
Dr Ivan Bakaltchev
Director
Company registration number 07120483 (England and Wales)
ASPIRE HEALTH AND CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
- 2 -
1
Accounting policies
Company information

Aspire Health And Care Limited is a private company limited by shares incorporated in England and Wales. The registered office is 35 Dovecote Lane, Beeston, Nottingham, Nottinghamshire, United Kingdom, NG9 1HR.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

ASPIRE HEALTH AND CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
5% Straight Line
Plant and equipment
15% Straight Line
Motor vehicles
25% Reducing Balance
1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

ASPIRE HEALTH AND CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
59
52
3
Tangible fixed assets
Leasehold land and buildings
Plant and equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 February 2024
651,804
208,877
83,936
944,617
Additions
-
0
6,438
-
0
6,438
At 31 January 2025
651,804
215,315
83,936
951,055
Depreciation and impairment
At 1 February 2024
-
0
123,181
34,207
157,388
Depreciation charged in the year
-
0
25,384
12,432
37,816
At 31 January 2025
-
0
148,565
46,639
195,204
Carrying amount
At 31 January 2025
651,804
66,750
37,297
755,851
At 31 January 2024
651,804
85,696
49,729
787,229
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
178,435
188,194
Amounts owed by group undertakings
130,415
-
0
Other debtors
14,610
14,326
Prepayments and accrued income
50,647
20,800
374,107
223,320
ASPIRE HEALTH AND CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 5 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Obligations under finance leases
7
8,590
8,590
Trade creditors
33,509
84,846
Amounts owed to group undertakings
40,000
40,000
Corporation tax
123,328
77,105
Other taxation and social security
74,428
52,087
Other creditors
5,304
525
Accruals and deferred income
122,651
128,028
407,810
391,181
6
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
12,690
21,279
7
Finance lease obligations
2025
2024
Future minimum lease payments due under finance leases:
£
£
Within one year
8,590
8,590
In two to five years
12,690
21,279
21,280
29,869
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Allotted, called up and fully paid of £1 each
1
1
1
1
2025-01-31 2024-02-01 false false false 10 October 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Dr Ivan Bakaltchev 07120483 2024-02-01 2025-01-31 07120483 2025-01-31 07120483 2024-01-31 07120483 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-01-31 07120483 core:PlantMachinery 2025-01-31 07120483 core:MotorVehicles 2025-01-31 07120483 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-01-31 07120483 core:PlantMachinery 2024-01-31 07120483 core:MotorVehicles 2024-01-31 07120483 core:ShareCapital 2025-01-31 07120483 core:ShareCapital 2024-01-31 07120483 core:RetainedEarningsAccumulatedLosses 2025-01-31 07120483 core:RetainedEarningsAccumulatedLosses 2024-01-31 07120483 core:ShareCapitalOrdinaryShareClass1 2025-01-31 07120483 core:ShareCapitalOrdinaryShareClass1 2024-01-31 07120483 bus:Director1 2024-02-01 2025-01-31 07120483 core:LandBuildings core:LongLeaseholdAssets 2024-02-01 2025-01-31 07120483 core:PlantMachinery 2024-02-01 2025-01-31 07120483 core:MotorVehicles 2024-02-01 2025-01-31 07120483 2023-02-01 2024-01-31 07120483 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-01-31 07120483 core:PlantMachinery 2024-01-31 07120483 core:MotorVehicles 2024-01-31 07120483 2024-01-31 07120483 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-02-01 2025-01-31 07120483 core:CurrentFinancialInstruments 2025-01-31 07120483 core:CurrentFinancialInstruments 2024-01-31 07120483 core:Non-currentFinancialInstruments 2025-01-31 07120483 core:Non-currentFinancialInstruments 2024-01-31 07120483 core:WithinOneYear 2025-01-31 07120483 core:WithinOneYear 2024-01-31 07120483 core:BetweenTwoFiveYears 2025-01-31 07120483 core:BetweenTwoFiveYears 2024-01-31 07120483 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 07120483 bus:OrdinaryShareClass1 2025-01-31 07120483 bus:OrdinaryShareClass1 2024-01-31 07120483 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 07120483 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 07120483 bus:FRS102 2024-02-01 2025-01-31 07120483 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 07120483 bus:FullAccounts 2024-02-01 2025-01-31 xbrli:pure xbrli:shares iso4217:GBP